Skip to main content

Devices and technology

Obesity

Overweight person and injection pen

27-04-2022 | Tirzepatide | News

Tirzepatide reduces liver fat, improves time in range

The publication of two SURPASS-3 substudies in The Lancet Diabetes & Endocrinology reveals significant benefits of tirzepatide on liver and abdominal fat in people with type 2 diabetes, as well as on time in target glucose range.

10-05-2018 | Devices and technology | Review | Article

Diabetes care in the digital era: A synoptic overview

Fatehi F, Menon A, Bird D. Curr Diab Rep 2018; 18: 38. doi: 10.1007/s11892-018-1013-5

18-04-2018 | Obesity | Review | Article

Social media and obesity in adults: A review of recent research and future directions

Waring ME et al. Curr Diab Rep 2018; 18: 34. doi: 10.1007/s11892-018-1001-9

15-02-2018 | Obesity | Article

EndoBarrier®: A safe and effective novel treatment for obesity and type 2 diabetes?

Patel N et al. Obes Surg 2018; Advance online publication. doi: 10.1007/s11695-018-3123-1

03-01-2018 | Obesity | Book chapter | Article

Digital health and obesity: How technology could be the culprit and solution for obesity

Cooper M, Morton J. In: Digital Health. Edited by Rivas H, Wac K. Springer, Cham, 2018. doi: 10.1007/978-3-319-61446-5_12

23-09-2017 | Mobile technology | Review | Article

Technology interventions to manage food intake: Where are we now?

Allman-Farinelli M, Gemming L. Curr Diab Rep 2017; 17: 103. doi: 10.1007/s11892-017-0937-5

23-09-2017 | Mobile technology | Review | Article

A review of technology-assisted interventions for diabetes prevention

Grock S et al. Curr Diab Rep 2017; 17: 107. doi: 10.1007/s11892-017-0948-2

18-04-2017 | Obesity | Review | Article

Filling the void: A review of intragastric balloons for obesity

Laing P et al. Dig Dis Sci 2017; 62: 1399–1408. doi: 10.1007/s10620-017-4566-2